Management of Indeterminate Hypoechoic Liver Lesions

Diagnostic Approach

The American College of Radiology recommends MRI with and without IV contrast as the first-line diagnostic test for characterizing indeterminate hypoechoic liver lesions, due to its high diagnostic accuracy of 95% 1, 2
MRI establishes a definitive diagnosis in 95% of liver lesions, versus 74-95% for CT, and only 1.5% require further imaging after MRI versus 10% after CT 2
Gadoxetate-enhanced MRI achieves 95-99% accuracy for hemangioma, 88-99% for focal nodular hyperplasia, and 97% for hepatocellular carcinoma 2

Multiphase contrast-enhanced CT with arterial, portal venous, and delayed phases using 2.5-5 mm slice thickness is an acceptable alternative to MRI if it is contraindicated or unavailable 1
The radiologist should specifically evaluate the enhancement pattern in arterial phase, lesion echogenicity correlation, and size and growth of the lesion 1, 3

Biopsy should be reserved for cases where imaging remains indeterminate after MRI or CT, as it carries a 9-12% bleeding risk and potential needle-track seeding risk 2
If imaging shows characteristic benign features, biopsy should be avoided entirely 2
Biopsy has a 30% false-negative rate for small lesions and may require multiple attempts, making it a suboptimal first-line diagnostic tool 3

If imaging shows benign characteristics, such as hemangioma or FNH with typical features, no further workup is needed and routine surveillance only is recommended 1, 2
If imaging shows malignant or indeterminate features, referral to hepatobiliary surgery or interventional radiology for image-guided biopsy with CEUS guidance is recommended 2
A multidisciplinary tumor board discussion should be held to determine if lesion characteristics warrant empiric treatment versus tissue diagnosis 1